Back to trial detailsIntake questionnaire
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Applying to Massachusetts General Hospital · Boston, Massachusetts
Answer a few short questions to share with the research team.
0 of 3 answered